Emergent BioSolutions (EBS) – Trader Talk
-
Emergent BioSolutions (EBS) gains 14% as FDA panel backs OTC use of its opioid overdose drug
-
Johnson & Johnson (JNJ) to End Covid-19 Vaccine Supply Deal With Emergent BioSolutions (EBS) - WSJ
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to EBS Stock Lookup